← All diseases

Disease Atlas / Disease detail

Hodgkin lymphoma

Educational draft summarizing the definition, symptoms, diagnosis, treatment, and evidence interpretation of Hodgkin lymphoma

Hodgkins lymphoma · HL · Hodgkin disease · Hodgkin lymphoma · Hodgkin's Disease · Hodgkin's disease · Hodgkin's lymphoma · Hodgkin's sarcoma · lymphoma, Hodgkin's · stage I subdiaphragmatic Hodgkin lymphoma · stage II subdiaphragmatic Hodgkin lymphoma

MONDO:0004952Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · 8903e3fd518b

Disease category
Hodgkin lymphoma (HL) is a type of cancer that occurs in the lymphatic system.
Key mechanism
The exact cause of Hodgkin lymphoma is not known.
Main causes · related factors
The lymphatic system is part of the immune system and consists of tissues and organs that produce, store, and transport white blood cells.
Representative patterns
Representative features include painless lymph node enlargement in the neck, armpits, or groin, fever of unknown origin, severe night sweats, weight loss, itching, and fatigue.
Individual differences
The risk is relatively higher in early adulthood (20–39 years) and late adulthood (65 years or older), and being male, past Epstein-Barr virus infection, and family history may be associated.
Diagnosis
Symptoms and prognosis may vary depending on the stage, tumor burden, and general condition, and the disease can progress if left untreated.
Management
Diagnosis is conducted by integrating medical history and physical examination with blood tests, CT/PET imaging, and lymph node biopsy.
Treatment/Research Status
A definitive diagnosis cannot be made based on symptoms or blood/imaging tests alone; biopsy results and stage evaluation must be interpreted together.
Read Evidence
Management is individualized in consultation with hematologic oncologists and others, considering stage, risk, treatment response, and the patient's overall condition.
Key Precautions
MedlinePlus lists treatment categories as chemotherapy, radiation therapy, targeted therapy, and cancer immunotherapy.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a Glance

Hodgkin lymphoma (HL) is a type of cancer that occurs in the lymphatic system.

Representative features include painless lymph node enlargement in the neck, armpits, or groin, fever of unknown origin, severe night sweats, weight loss, itching, and fatigue.

How the disease works

The exact cause of Hodgkin lymphoma is not known.

The lymphatic system is part of the immune system and consists of tissues and organs that produce, store, and transport white blood cells.

Variations in presentation among individuals

The risk is relatively higher in early adulthood (20–39 years) and late adulthood (65 years or older), and being male, past Epstein-Barr virus infection, and family history may be associated.

The broad framework of diagnosis and management

Symptoms and prognosis may vary depending on the stage, tumor burden, and general condition, and the disease can progress if left untreated.

Diagnosis is conducted by integrating medical history and physical examination with blood tests, CT/PET imaging, and lymph node biopsy.

Current status of treatment

A definitive diagnosis cannot be made based on symptoms or blood/imaging tests alone; biopsy results and stage evaluation must be interpreted together.

Management is individualized in consultation with hematologic oncologists and others, considering stage, risk, treatment response, and the patient's overall condition.

MedlinePlus lists treatment categories as chemotherapy, radiation therapy, targeted therapy, and cancer immunotherapy.

How to read clinical trials

After treatment, recurrence and late-term side effects can be monitored. The clonoSEQ Watch Registry on ClinicalTrials.gov is registered as an observational study but has a terminated status with no reported results.

Points to verify during clinical consultations

In clinical practice, accurate subtype and stage, biopsy/imaging results, treatment goals and expected side effects, fertility preservation, follow-up plans, and clinical trial eligibility can be verified.

Medical Guidance

This material is for educational purposes and is not intended as guidance for individual diagnosis or treatment.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.